Journal article
Reversible Ipecac Myopathy
Archives of neurology (Chicago), Vol.42(2), pp.188-190
02/01/1985
DOI: 10.1001/archneur.1985.04060020106024
PMID: 2858193
Abstract
• The abuse of ipecac syrup for three years resulted in painless, nonfatigable, chiefly proximal weakness in a 27-year-old woman. Electromyography (EMG) and a muscle biopsy revealed features of a myopathy similar to those previously reported in experimental emetine myopathy. Clinical weakness and EMG abnormalities improved after discontinuation of ipecac administration. A direct toxic action of ipecac (acting through its active alkaloid, emetine hydrochloride) on muscle fibers seemed to be responsible for the weakness in this patient.
Details
- Title: Subtitle
- Reversible Ipecac Myopathy
- Creators
- John E MateerBarbara J FarrellSamuel S. M ChouLudwig Gutmann
- Resource Type
- Journal article
- Publication Details
- Archives of neurology (Chicago), Vol.42(2), pp.188-190
- DOI
- 10.1001/archneur.1985.04060020106024
- PMID
- 2858193
- NLM abbreviation
- Arch Neurol
- ISSN
- 0003-9942
- eISSN
- 1538-3687
- Publisher
- American Medical Association
- Language
- English
- Date published
- 02/01/1985
- Academic Unit
- Neurology
- Record Identifier
- 9984020760102771
Metrics
18 Record Views